Epithelial-mesenchymal Transition Factor and Its Association With Mammographic Density and Breast Cancer Prognosis

被引:1
|
作者
Kim, Eun Young [1 ]
Ahn, Sangjeong [2 ,3 ]
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Surg, Sch Med, Seoul, South Korea
[2] Korea Univ, Anam Hosp, Coll Med, Dept Pathol, Seoul, South Korea
[3] Korea Univ, Anam Hosp, Coll Med, Dept Pathol, 73 Goryeodae ro, Seoul 02841, South Korea
关键词
Breast carcinoma; epithelial mesenchymal transition; mammographic breast density; prognosis; CELLS; EXPRESSION; CD34; PROGRESSION; VIMENTIN; INVASION; RISK;
D O I
10.21873/anticanres.16392
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: The tumor microenvironment influences tumor progression, invasion, and metastasis. This study determined the expression levels of epithelialmesenchymal transition (EMT) factors according to zone and their correlation with mammographic breast density and investigated the prognostic value of EMT factors. Patients and Methods: The clinical and pathological data of invasive carcinoma and ductal carcinoma in situ were reviewed. Primary breast tissue samples were evaluated using immunohistochemistry (IHC) staining of the EMTassociated markers, including alpha-SMA, vimentin, MMP-9, and CD34. The expression levels were analyzed in three areas: the tumor center, interface, and distal zones. EMT factors were correlated with mammographic breast density and oncologic outcomes. Results: An overall EMT phenotype conversion from positive to negative was seen in 55.7% of alpha-SMA- and 34.4% of MMP-9-positive cells between the tumor center and interface zones, which was significantly different (p<0.05). Most changes in EMT expression from the center to the distal zone were from positive to negative, but 23.0% of CD34-expressing cells showed negative to positive conversion. The proportion of alpha-SMA, vimentin, and MMP-9 expression was higher in the non-dense breast group compared to the dense breast group in the interface and distal zones (p<0.05). CD34 expression in the distal zone was an independent favorable prognostic factor for disease-free survival (p=0.039). Conclusion: The differential expression of EMT markers in each zone suggests heterogeneous cancer cell populations within each zone of breast cancer. EMT factor expression can also interplay between breast density stroma and geographical tumor zone.
引用
收藏
页码:2281 / 2292
页数:12
相关论文
共 50 条
  • [1] Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma
    Sowa, Terumasa
    Menju, Toshi
    Sonobe, Makoto
    Nakanishi, Takao
    Shikuma, Kei
    Imamura, Naoto
    Motoyama, Hideki
    Hijiya, Kyoko
    Aoyama, Akihiro
    Chen, Fengshi
    Sato, Toshihiko
    Kobayashi, Masashi
    Yoshizawa, Akihiko
    Haga, Hironori
    Sozu, Takashi
    Date, Hiroshi
    CANCER MEDICINE, 2015, 4 (12): : 1853 - 1862
  • [2] SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro
    Wang, L.
    Zhang, J.
    Yang, X.
    Chang, Y. W. Y.
    Qi, M.
    Zhou, Z.
    Zhang, J.
    Han, B.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (04) : 301 - 307
  • [3] Epithelial-Mesenchymal Transition: Clinical Implications for Nodal Metastasis and Prognosis of Tongue Cancer
    Han, Myung Woul
    Lee, Jong Cheol
    Kim, Young Min
    Cha, Hee Jeong
    Roh, Jong-Lyel
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Cho, Kyung-Ja
    Kim, Seong Who
    Kim, Sang Yoon
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 152 (01) : 80 - 86
  • [4] ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer
    Gao, Zhao-Hua
    Lu, Chong
    Wang, Zhen-Ning
    Song, Yong-Xi
    Zhu, Jin-Liang
    Gao, Peng
    Sun, Jing-Xu
    Chen, Xiao-Wan
    Wang, Mei-Xian
    Dong, Yu-Lan
    Xu, Hui-Mian
    HISTOPATHOLOGY, 2014, 65 (04) : 527 - 538
  • [5] Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?
    Jiang, Jia-Hao
    Liu, Chen
    Cheng, He
    Lu, Yu
    Qin, Yi
    Xu, Yong-Feng
    Xu, Jin
    Long, Jiang
    Liu, Liang
    Ni, Quan-Xing
    Yu, Xian-Jun
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2015, 1855 (01): : 43 - 49
  • [6] Epithelial-Mesenchymal Transition (EMT) and Prostate Cancer
    Odero-Marah, Valerie
    Hawsawi, Ohuod
    Henderson, Veronica
    Sweeney, Janae
    CELL & MOLECULAR BIOLOGY OF PROSTATE CANCER: UPDATES, INSIGHTS AND NEW FRONTIERS, 2018, 1095 : 101 - 110
  • [7] Epithelial-mesenchymal Transition and Its Role in the Pathogenesis of Colorectal Cancer
    Zhu, Qing-Chao
    Gao, Ren-Yuan
    Wu, Wen
    Qin, Huan-Long
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (05) : 2689 - 2698
  • [8] Dynamic Transcription Factor Networks in Epithelial-Mesenchymal Transition in Breast Cancer Models
    Siletz, Anaar
    Schnabel, Michael
    Kniazeva, Ekaterina
    Schumacher, Andrew J.
    Shin, Seungjin
    Jeruss, Jacqueline S.
    Shea, Lonnie D.
    PLOS ONE, 2013, 8 (04):
  • [9] Epithelial-mesenchymal transition and drug resistance in breast cancer
    Huang, Jing
    Li, Hongzhong
    Ren, Guosheng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 840 - 848
  • [10] The prognostic significanc of epithelial-mesenchymal transition in breast cancer
    Fuchs, IB
    Lichtenegger, W
    Buehler, H
    Henrich, W
    Stein, H
    Kleine-Tebbe, A
    Schaller, G
    ANTICANCER RESEARCH, 2002, 22 (6A) : 3415 - 3419